These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 2910471
1. Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Hennipman A, van Oirschot BA, Smits J, Rijksen G, Staal GE. Cancer Res; 1989 Feb 01; 49(3):516-21. PubMed ID: 2910471 [Abstract] [Full Text] [Related]
2. [Tyrosine-protein kinase activity in breast neoplasm. Comparison with activity obtained in benign diseases and in normal tissues]. Pierart J, Oñate E, Klaassen R, Cid L, Gutierrez S, Talbot E, Ross E, Zambrano C, Burmeister R, Puchi M. Rev Med Chil; 1995 Feb 01; 123(2):165-75. PubMed ID: 7569456 [Abstract] [Full Text] [Related]
3. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA, Staal GE. Cancer Res; 1992 Sep 01; 52(17):4773-8. PubMed ID: 1380891 [Abstract] [Full Text] [Related]
4. Histochemically demonstrable phosphotyrosyl-protein phosphatase in normal human breast, in benign breast diseases and in breast cancer. Partanen S, Pekonen F. Anticancer Res; 1989 Sep 01; 9(3):667-71. PubMed ID: 2548434 [Abstract] [Full Text] [Related]
5. Protein tyrosine kinase activity in breast cancer and its relation to prognostic indicators. Kopreski MS, Witters L, Brennan WA, Buckwalter EA, Chinchilli VM, Demers LM, Lipton A. Anticancer Res; 1996 Sep 01; 16(5B):3037-41. PubMed ID: 8920763 [Abstract] [Full Text] [Related]
6. Enzyme activities in normal, dysplastic, and cancerous human breast tissues. Balinsky D, Platz CE, Lewis JW. J Natl Cancer Inst; 1984 Feb 01; 72(2):217-24. PubMed ID: 6582310 [Abstract] [Full Text] [Related]
7. Tyrosine kinase activities in normal and neoplastic epithelia tissue of the human upper aero-digestive tract. Rydell EL, Olofsson J, Hellem S, Axelsson KL. Second Messengers Phosphoproteins; 1991 Feb 01; 13(4):217-29. PubMed ID: 1812286 [Abstract] [Full Text] [Related]
8. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer]. He GP, Shui QL, Huang Y, Zhang SZ, Yu H. Ai Zheng; 2004 Sep 01; 23(9):1041-6. PubMed ID: 15363198 [Abstract] [Full Text] [Related]
9. Clinical relevance of protein-tyrosine (de-)phosphorylation in head and neck cancer. Verschuur HP, Wynne HJ, Slootweg PJ, van Langen J, Staal GE, Rijksen G, Hordijk GJ. Laryngoscope; 1995 Nov 01; 105(11):1238-44. PubMed ID: 7475883 [Abstract] [Full Text] [Related]
10. Isozyme patterns of normal, benign, and malignant human breast tissues. Balinsky D, Platz CE, Lewis JW. Cancer Res; 1983 Dec 01; 43(12 Pt 1):5895-901. PubMed ID: 6640538 [Abstract] [Full Text] [Related]
11. Plasminogen activators and steroid receptor concentrations in normal, benign, and malignant breast and ovarian tissues. Isotalo H, Tryggvason K, Vierikko P, Kauppila A, Vihko R. Anticancer Res; 1983 Dec 01; 3(5):331-5. PubMed ID: 6685990 [Abstract] [Full Text] [Related]
12. Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up. Mansour OA, Zekri AR, Harvey J, Teramoto Y, el-Ahmady O. Anticancer Res; 1997 Dec 01; 17(4B):3101-6. PubMed ID: 9329611 [Abstract] [Full Text] [Related]
13. gamma-Glutamyl transpeptidase activity in benign and malignant human mammary epithelial lesions. Histochemical evaluation. Levine SE, Budwit DA, Michalopoulos GK, Georgiade GS, McCarty KS. Arch Pathol Lab Med; 1983 Aug 01; 107(8):423-7. PubMed ID: 6135407 [Abstract] [Full Text] [Related]
14. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Resnik JL, Reichart DB, Huey K, Webster NJ, Seely BL. Cancer Res; 1998 Mar 15; 58(6):1159-64. PubMed ID: 9515800 [Abstract] [Full Text] [Related]
15. Reduced nonspecific steroidal esterase activity in human malignant tumor tissue from liver, colon and breast when compared to peritumoral and normal tissue levels. Lund-Pero M, Jeppson B, Pero RW. Anticancer Res; 1994 Mar 15; 14(6B):2747-53. PubMed ID: 7872712 [Abstract] [Full Text] [Related]
16. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity. Zaffaroni N, Della Porta C, Villa R, Botti C, Buglioni S, Mottolese M, Grazia Daidone M. J Pathol; 2002 Sep 15; 198(1):37-46. PubMed ID: 12210061 [Abstract] [Full Text] [Related]
17. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G. Cancer Res; 1993 Jul 01; 53(13):3198-206. PubMed ID: 7686450 [Abstract] [Full Text] [Related]
18. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression. Bhargava R, Naeem R, Marconi S, Luszcz J, Garb J, Gasparini R, Otis CN. Hum Pathol; 2001 Dec 01; 32(12):1344-50. PubMed ID: 11774167 [Abstract] [Full Text] [Related]
19. Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Hennipman A, Smits J, van Oirschot B, van Houwelingen JC, Rijksen G, Neyt JP, Van Unnik JA, Staal GE. Tumour Biol; 1987 Dec 01; 8(5):251-63. PubMed ID: 3448771 [Abstract] [Full Text] [Related]
20. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Kelly T, Kechelava S, Rozypal TL, West KW, Korourian S. Mod Pathol; 1998 Sep 01; 11(9):855-63. PubMed ID: 9758365 [Abstract] [Full Text] [Related] Page: [Next] [New Search]